Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Particulate delivery systems for biodefense subunit vaccines.

Vincent W Bramwell1, Jim E Eyles, H Oya Alpar

  • 1School of Pharmacy, University of London, 29-39 Brunswick Square, London, WC1N 1AX, UK.

Advanced Drug Delivery Reviews
|June 7, 2005
PubMed
Summary

Particulate vaccines using liposomes and polymers show promise for biowarfare threats like plague and Ebola. Further development is needed to translate animal model success into human vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.

International journal of pharmaceutics·2019
Same author

Nasal vaccination with poly(β-amino ester)-poly(d,l-lactide-co-glycolide) hybrid nanoparticles.

International journal of pharmaceutics·2017
Same author

In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity.

Vaccine·2016
Same author

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.

Journal of microencapsulation·2015
Same author

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies.

Journal of microencapsulation·2015
Same author

Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study.

The Journal of pharmacy and pharmacology·2015

Area of Science:

  • Vaccinology
  • Biodefense
  • Nanotechnology in Medicine

Background:

  • Subunit antigens and correlates of protection are advancing vaccine development.
  • Particulate delivery systems offer significant potential but face challenges in human application.

Purpose of the Study:

  • To review the development status of particulate vaccines.
  • Focus on liposomes and biodegradable polymers for biowarfare and filovirus agents.

Main Methods:

  • Literature review of particulate vaccine development.
  • Focus on specific biowarfare agents (plague, anthrax, botulinum, smallpox) and filoviruses (Marburg, Ebola).

Main Results:

  • Encouraging results in animal models for particulate vaccines.

Related Experiment Videos

  • Challenges remain in translating these findings to effective human vaccines.

    • Conclusions:

    • Particulate vaccines, particularly liposomes and polymers, are a key area for biodefense research.
    • Continued research is essential to overcome barriers to human vaccine deployment against these threats.